Literature DB >> 25891417

Flavonoids casticin and chrysosplenol D from Artemisia annua L. inhibit inflammation in vitro and in vivo.

Yu-Jie Li1, Yan Guo1, Qing Yang1, Xiao-Gang Weng1, Lan Yang1, Ya-Jie Wang1, Ying Chen1, Dong Zhang1, Qi Li1, Xu-Cen Liu1, Xiao-Xi Kan1, Xi Chen1, Xiao-Xin Zhu2, Eva Kmoníèková3, Zdenìk Zídek4.   

Abstract

BACKGROUND: The aim of our experiments was to investigate the anti-inflammatory properties of casticin and chrysosplenol D, two flavonoids present in Artemisia annua L.
METHODS: Topical inflammation was induced in ICR mice using croton oil. Mice were then treated with casticin or chrysosplenol D. Cutaneous histological changes and edema were assessed. ICR mice were intragastrically administrated with casticin or chrysosplenol D followed by intraperitoneal injection of lipopolysaccharide (LPS). Mouse Raw264.7 macrophage cells were incubated with casticin or chrysosplenol D. Intracellular phosphorylation was detected, and migration was assessed by trans-well assay. HT-29/NFκB-luc cells were incubated with casticin or chrysosplenol D in the presence or absence of LPS, and NF-κB activation was quantified.
RESULTS: In mice, administration of casticin (0.5, 1 and 1.5μmol/cm(2)) and chrysosplenol D (1 and 1.5μmol/cm(2)) inhibited croton oil-induced ear edema (casticin: 29.39-64.95%; chrysosplenol D: 37.76-65.89%, all P<0.05) in a manner similar to indomethacin (0.5, 1 and 1.5μmol/cm(2); 55.63-84.58%). Casticin (0.07, 0.13 and 0.27mmol/kg) and chrysosplenol D (0.07, 0.14 and 0.28mmol/kg) protected against LPS-induced systemic inflammatory response syndrome (SIRS) in mice (all P<0.05), in a manner similar to dexamethasone (0.03mmol/kg). Casticin and chrysosplenol D suppressed LPS-induced release of IL-1 beta, IL-6 and MCP-1, inhibited cell migration, and reduced LPS-induced IκB and c-JUN phosphorylation in Raw264.7 cells. JNK inhibitor SP600125 blocked the inhibitory effect of chrysosplenol D on cytokine release.
CONCLUSIONS: The flavonoids casticin and chrysosplenol D from A. annua L. inhibited inflammation in vitro and in vivo.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Artemisia annua L.; Casticin; Chrysosplenol D; Flavonoids; Inflammation

Mesh:

Substances:

Year:  2015        PMID: 25891417     DOI: 10.1016/j.taap.2015.04.005

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  18 in total

1.  It is not just artemisinin: Artemisia sp. for treating diseases including malaria and schistosomiasis.

Authors:  B M Gruessner; L Cornet-Vernet; M R Desrosiers; P Lutgen; M J Towler; P J Weathers
Journal:  Phytochem Rev       Date:  2019-09-19       Impact factor: 5.374

2.  Casticin Improves Respiratory Dysfunction and Attenuates Oxidative Stress and Inflammation via Inhibition of NF-ĸB in a Chronic Obstructive Pulmonary Disease Model of Chronic Cigarette Smoke-Exposed Rats.

Authors:  Jie Li; Chen Qiu; Peng Xu; Yongzhen Lu; Rongchang Chen
Journal:  Drug Des Devel Ther       Date:  2020-11-17       Impact factor: 4.162

3.  Casticin Inhibits In Vivo Growth of Xenograft Tumors of Human Oral Cancer SCC-4 Cells.

Authors:  Hung-Sheng Shang; Kuo-Wei Chen; Jiann-Shang Chou; Shu-Fen Peng; Yung-Liang Chen; Po-Yuan Chen; Hsieh-Chou Huang; Hsu-Feng Lu; Hsin-Yu Chang; Yung-Luen Shih; Wen-Wen Huang
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

4.  Epigenetic control of UV-B-induced flavonoid accumulation in Artemisia annua L.

Authors:  Neha Pandey; Niraj Goswami; Deepika Tripathi; Krishna Kumar Rai; Sanjay Kumar Rai; Shilpi Singh; Shashi Pandey-Rai
Journal:  Planta       Date:  2018-09-28       Impact factor: 4.116

5.  Effects of Artemisia argyi flavonoids on growth performance and immune function in broilers challenged with lipopolysaccharide.

Authors:  Shuo Yang; Jing Zhang; Yang Jiang; Yuan Qing Xu; Xiao Jin; Su Mei Yan; Bin Lin Shi
Journal:  Anim Biosci       Date:  2021-01-01

6.  Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signaling pathway.

Authors:  Ling Zhou; Xiaoying Dong; Linlin Wang; Lanlan Shan; Ting Li; Wanfu Xu; Yan Ding; Mingqiang Lai; Xiaojun Lin; Meng Dai; Xiaochun Bai; Chunhong Jia; Hang Zheng
Journal:  Oncotarget       Date:  2017-04-27

7.  Assessing the Anti-inflammatory Mechanism of Reduning Injection by Network Pharmacology.

Authors:  Fuda Xie; Mingxiang Xie; Yibing Yang; Miaomiao Zhang; Xiaojie Xu; Na Liu; Wei Xiao; Jiangyong Gu
Journal:  Biomed Res Int       Date:  2020-12-16       Impact factor: 3.411

Review 8.  Artemisia annua, a Traditional Plant Brought to Light.

Authors:  Axelle Septembre-Malaterre; Mahary Lalarizo Rakoto; Claude Marodon; Yosra Bedoui; Jessica Nakab; Elisabeth Simon; Ludovic Hoarau; Stephane Savriama; Dominique Strasberg; Pascale Guiraud; Jimmy Selambarom; Philippe Gasque
Journal:  Int J Mol Sci       Date:  2020-07-15       Impact factor: 5.923

9.  Silver ion bioreduction in nanoparticles using Artemisia annua L. extract: characterization and application as antibacterial agents.

Authors:  Anush Aghajanyan; Lilit Gabrielyan; Robin Schubert; Armen Trchounian
Journal:  AMB Express       Date:  2020-04-07       Impact factor: 3.298

10.  Dried Leaf Artemisia Annua Improves Bioavailability of Artemisinin via Cytochrome P450 Inhibition and Enhances Artemisinin Efficacy Downstream.

Authors:  Matthew R Desrosiers; Alexis Mittelman; Pamela J Weathers
Journal:  Biomolecules       Date:  2020-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.